Navigation Links
Award Winning Mayo Clinic Scientist Joins Cardio3 BioSciences
Date:7/14/2010

MONT-SAINT-GUIBERT, Belgium, July 14, 2010 /PRNewswire/ --

- Dr. Atta Behfar Recognised With Prestigious Award for Science Behind Cardio3 BioSciences' C-Cure Technology

Cardio3 BioSciences, a leading Belgian biotechnology company specialising in regenerative therapies for the treatment of cardiovascular diseases, today announces that Dr. Atta Behfar is joining its research and development laboratories as Director for Advanced Research. Dr. Atta Behfar, one of the key scientists involved in the development of C-Cure(R), will spend a year at Cardio3 BioSciences on assignment from Mayo Clinic to develop and strengthen the research pipeline.

Dr. Behfar is a member of the clinician investigator program in cardiology at the Mayo Clinic in Rochester, Minnesota, USA and has played a key role in the research underlying Cardio3 BioSciences' lead product, C-Cure, a revolutionary stem cell treatment for heart failure. His work was recognised by the Herman K. Gold Young Investigator Award at the Annual American College of Cardiology meeting in March 2010, in Georgia, Atlanta highlighting the quality of the science behind Cardio3 BioSciences' approach.

C-Cure is designed to reprogram the patient's own stem cells into new heart cells to rebuild the heart. Dr Behfar has played an active part in developing the technology that directs the patient's cells to become cardiopoietic cells - cells 'programmed' to become new heart muscle cells when injected back into the heart of a patient, replacing those cells lost during heart failure and re
'/>"/>

SOURCE Cardio3 BioSciences
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
2. Federal Funding Awarded to Test Antimicrobial Properties of Copper Metals
3. Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Companys Anthrax Therapeutic
4. Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies
5. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
6. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
7. Nobel Prize Awarded to Foundation for Biomedical Research Board Member
8. National Jewish, Brigham and Womens Awarded $37 Million to Identify Genes and Other Risk Factors that Influence the Development of COPD
9. Abbotts m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
10. SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases
11. Congressional Funds Awarded for Testing of Antimicrobial Copper Metals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , May 22, 2015  BioLife Solutions, Inc. (NASDAQ: ... proprietary clinical grade hypothermic storage and cryopreservation ... for cells and tissues ("BioLife" or the "Company"), announced that ... MicroCap Conference. The Company is scheduled to ... May 27, 2015 at the Grand Hyatt Hotel in ...
(Date:5/22/2015)... Md. , May 22, 2015  RegeneRx Biopharmaceuticals, ... on tissue protection, repair and regeneration, today announced that ... is scheduled to present a corporate overview at two ... present at the SeeThruEquity 4 th Annual Microcap ... New York City at 11:00 am EDT. ...
(Date:5/22/2015)... -- According to a new market research ... Services), by Test Type (Indirect, Enzyme-based, Reactive Oxygen Species ... Users - Global Forecast to 2020", published by MarketsandMarkets, the ... $736.85 Million by 2020 from $452.36 Million in 2015, ... Browse 71 market data Tables and 90 Figures spread ...
Breaking Medicine Technology:BioLife Solutions To Present At The 2015 Marcum MicroCap Conference In New York City 2RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 4
... Jan. 20, 2011 Aubrey Inc. – http://www.aubreyinc.com ... and product evaluation phase of its second generation product, ... production and currently available for purchase.  Founder Aubrey Woodroof, ... advance the art once again.  "It is a wonderful ...
... FRANCISCO, Jan. 20, 2011 TheCarrot.com , ... health engagement programs, announced the immediate availability of ... expertise of the University of California at San ... combines proven behavior modification methodology with TheCarrot.com,s award-winning ...
Cached Medicine Technology:Aubrey Inc. Releases New Advanced Biosynthetic Wound Care Product 'AWBAT Plus' 2TheCarrot.com Launches Quit Smoking Program 2TheCarrot.com Launches Quit Smoking Program 3
(Date:5/22/2015)... 2015 Combination therapy, or polytherapy, ... chronic obstructive pulmonary disorder (COPD) as the dominant ... plc as well as Germany’s Boehringer Ingelheim compete ... But will market payers, clinicians and patients be ... to completely new ones? , In spite of ...
(Date:5/22/2015)... Carnegie Science Center and ... new partnership to develop BodyTech, a dynamic, three-pronged health ... includes a new exhibit at the Science Center called ... a new traveling science show, Anatomy Adventure, which will ... , Designed to explore a wide range of topics ...
(Date:5/22/2015)... 22, 2015 Power Systems is proud to ... 2015 race season. Drobeck is in his second year of ... firefighter with the Missoula Fire Department in Missoula, MT. He ... in 2014. During his career, he has had 15 1st ... recorded top 10 finishes in all seven of his 2014 ...
(Date:5/22/2015)... 2015 The dentist in ... that they are now offering complimentary consultations to ... treatments. At consultations, patients can discuss their candidacy ... certain treatments can achieve and whether alternative options ... initial appointment. If treatments are chosen, patients can ...
(Date:5/22/2015)... 2015 A Phase 3 French ... Society of Clinical Oncology (ASCO)’s annual meeting at ... for those patients who received bevacizumab in addition ... Bevacizumab (Avastin® Genentech, Inc.) is an antibody that ... already routinely used to treat many other cancers, ...
Breaking Medicine News(10 mins):Health News:Chronic Obstructive Pulmonary Disorder Therapeutics Market Discussed in In-demand FirstWord Report Published at MarketPublishers.com 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2
... A survey conducted among many Canadian households has revealed ... unable to realize timely medical guidance and facilities,// especially ... ,The Decima poll conducted amongst 3,000 Canadians has shown ... during the previous three months and felt the waiting ...
... Disease Laboratory in Bhopal have finally helped to materialize India's ... H5N1 bird flu virus last month. However, several obstacles lay ... vaccine. ,This is because there is not a ... poultry who has a Bio Safety Level (BSL) 3 lab, ...
... of strategies to combat cervical abnormalities; the worlds first ever ... the market. , ,A feather in the cap ... brain behind this vaccine, who has relentlessly worked on this ... the inaugural shot. This vaccine is powerful in containing the ...
... online interaction between Britain and India, British pupils are ... on various subjects from teachers based in India.// ... one-to-one tuition using Internet telephony from TutorVista, a company ... in shifts. ,While such services have been ...
... awarded a 63-year-old doctor of Indian origin a four-year ... patients over a 13-year //period between September 1991 and ... qualified in India, moved to Britain in 1973. He ... His one-man practice had 2,900 patients. He began his ...
... Board (MPPEB) will hold afresh next month the Dental and ... dental colleges. // ,The test conducted Aug 13 ... probed the complaints cancelled the examination Aug 19. ... examinations in a way so that the results can be ...
Cached Medicine News:Health News:Major Hurdle towards Development of Bird Flu Vaccine in India. 2Health News:British Pupils Opt for Online Tuition from India 2Health News:Indian Doctor in Britain Jailed for Molesting Patients 2
The Bard Ellik Bladder Evacuator is designed for ease of maneuverability during the removal of tissue sections during transurethral prostatectomy, TURPs, bladder biopsy, etc....
... table comes in two modelsthe BT4, which ... BT5, which offers five. With the simple ... to suit your needs. Both models ... side rails, ankle/foot supports, adjustable arm boards, ...
The design of this table top is based on advanced functionality for specific urological requirements. This composite product sets a new standard for urological imaging....
5 Part Differential Auto Hematology Analyzer.,Top of the range Cell Counter for medium-sized laboratories....
Medicine Products: